Description
The D-Dimer Fluorescence ImmunoAssay (FIA) Test is a lateral flow chromatographic fluorescence immunoassay for the quantitative detection of D-Dimer in human plasma or whole blood using the RaFIA system. This test is intended for in vitro diagnostic use only.
D-Dimer is the fibrinolysis-specific degradation product found in human blood. D-Dimer is not normally present in human blood, except when the coagulation system has been activated, for instance because of the presence of thrombosis or disseminated intravascular coagulation. Therefore, D-Dimer is commonly used to exclude thromboembolic disease where the probability is low. While a negative result may rule out thrombosis, a positive result can indicate thrombosis but does not rule out other potential causes. In addition, D-Dimer can be used in the diagnosis of blood disorders disseminated by intravascular coagulation. Myocardial infarction, cerebral infarction, pulmonary embolism, venous thrombosis, surgery, cancer, disseminated intravascular coagulation, infection and tissue necrosis may lead to elevated concentration of D-Dimer. Increased concentration of D-Dimer may also be observed in the elderly or hospitalized patients with abnormal coagulation caused by bacteremia.
The D-Dimer FIA Test was developed to detect D-Dimer in human plasma or whole blood within 3 minutes, without the use of cumbersome laboratory equipment, and requiring minimally trained laboratory personnel.